A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease

Cell

Volumn 169, Issue 7, 2017, Pages 1276-1290.e17

  Keren Shaul, Hadas ^a   Spinrad, Amit ^a   Weiner, Assaf ^a,b   Matcovitch Natan, Orit ^a   Dvir Szternfeld, Raz ^a   Ulland, Tyler K ^c   David, Eyal ^a   Baruch, Kuti ^a   Lara Astaiso, David ^a   Toth, Beata ^a   Itzkovitz, Shalev ^a   Colonna, Marco ^c   Schwartz, Michal ^a   Amit, Ido ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; immunology; microglia; single cell RNA seq; systems biology

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; BRAIN SLICE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; IMMUNOCOMPETENT CELL; MICROGLIA; NERVE DEGENERATION; NEUROIMMUNOLOGY; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SINGLE CELL ANALYSIS; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; SEQUENCE ANALYSIS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; NEURODEGENERATIVE DISEASES; PHAGOCYTES; RECEPTORS, IMMUNOLOGIC; SEQUENCE ANALYSIS, RNA; SINGLE-CELL ANALYSIS;

EID: 85020287843     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.05.018     Document Type: Article

References (88)

1. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., Jones, E., Alzheimer's disease. Lancet 377 (2011), 1019–1031.
2. Baruch, K., Rosenzweig, N., Kertser, A., Deczkowska, A., Sharif, A.M., Spinrad, A., Tsitsou-Kampeli, A., Sarel, A., Cahalon, L., Schwartz, M., Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat. Commun., 6, 2015, 7967.
3. Baruch, K., Deczkowska, A., Rosenzweig, N., Tsitsou-Kampeli, A., Sharif, A.M., Matcovitch-Natan, O., Kertser, A., David, E., Amit, I., Schwartz, M., PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease. Nat. Med. 22 (2016), 135–137.
4. Baum, L., Chen, L., Masliah, E., Chan, Y.S., Ng, H.K., Pang, C.P., Lipoprotein lipase mutations and Alzheimer's disease. Am. J. Med. Genet. 88 (1999), 136–139.
5. Bendall, S.C., Davis, K.L., Amir, A.D., Tadmor, M.D., Simonds, E.F., Chen, T.J., Shenfeld, D.K., Nolan, G.P., Pe'er, D., Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell 157 (2014), 714–725.
6. Butovsky, O., Jedrychowski, M.P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D.J., Wu, P.M., Doykan, C.E., Kiner, O., et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann. Neurol. 77 (2015), 75–99.
7. Castellano, J.M., Kim, J., Stewart, F.R., Jiang, H., DeMattos, R.B., Patterson, B.W., Fagan, A.M., Morris, J.C., Mawuenyega, K.G., Cruchaga, C., et al. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med., 3, 2011, 89ra57.
8. Chakrabarty, P., Li, A., Ceballos-Diaz, C., Eddy, J.A., Funk, C.C., Moore, B., DiNunno, N., Rosario, A.M., Cruz, P.E., Verbeeck, C., et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron 85 (2015), 519–533.
9. Chiu, I.M., Morimoto, E.T., Goodarzi, H., Liao, J.T., O'Keeffe, S., Phatnani, H.P., Muratet, M., Carroll, M.C., Levy, S., Tavazoie, S., et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4 (2013), 385–401.
10. Colonna, M., Wang, Y., TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat. Rev. Neurosci. 17 (2016), 201–207.
11. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993), 921–923.
12. Deardorff, W.J., Grossberg, G.T., Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics. Expert Rev. Neurother. 17 (2017), 17–32.
13. Deng, Q., Ramsköld, D., Reinius, B., Sandberg, R., Single-cell RNA-seq reveals dynamic, random monoallelic gene expression in mammalian cells. Science 343 (2014), 193–196.
14. Elowitz, M.B., Levine, A.J., Siggia, E.D., Swain, P.S., Stochastic gene expression in a single cell. Science 297 (2002), 1183–1186.
15. Geissmann, F., Gordon, S., Hume, D.A., Mowat, A.M., Randolph, G.J., Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 10 (2010), 453–460.
16. Ginhoux, F., Prinz, M., Origin of microglia: current concepts and past controversies. Cold Spring Harb. Perspect. Biol., 7, 2015, a020537.
17. Grün, D., Lyubimova, A., Kester, L., Wiebrands, K., Basak, O., Sasaki, N., Clevers, H., van Oudenaarden, A., Single-cell messenger RNA sequencing reveals rare intestinal cell types. Nature 525 (2015), 251–255.
18. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S., Younkin, S., et al., Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368 (2013), 117–127.
19. Guillot-Sestier, M.V., Doty, K.R., Gate, D., Rodriguez, J. Jr., Leung, B.P., Rezai-Zadeh, K., Town, T., Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85 (2015), 534–548.
20. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994), 1772–1775.
21. Gury-BenAri, M., Thaiss, C.A., Serafini, N., Winter, D.R., Giladi, A., Lara-Astiaso, D., Levy, M., Salame, T.M., Weiner, A., David, E., et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166 (2016), 1231–1246.
22. Hanisch, U.-K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007), 1387–1394.
23. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
24. Haynes, S.E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M.E., Gan, W.B., Julius, D., The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9 (2006), 1512–1519.
25. Heppner, F.L., Ransohoff, R.M., Becher, B., Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16 (2015), 358–372.
26. Hickman, S.E., El Khoury, J., TREM2 and the neuroimmunology of Alzheimer's disease. Biochem. Pharmacol. 88 (2014), 495–498.
27. Hickman, S.E., Kingery, N.D., Ohsumi, T.K., Borowsky, M.L., Wang, L.C., Means, T.K., El Khoury, J., The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16 (2013), 1896–1905.
28. Holtman, I.R., Raj, D.D., Miller, J.A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P.D., Möller, T., Orre, M., Kamphuis, W., et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol. Commun., 3, 2015, 31.
29. Holtzman, D.M., Morris, J.C., Goate, A.M., Alzheimer's disease: the challenge of the second century. Sci. Transl. Med., 3, 2011, 77sr1.
30. Hume, D.A., Macrophages as APC and the dendritic cell myth. J. Immunol. 181 (2008), 5829–5835.
31. Itzkovitz, S., Blat, I.C., Jacks, T., Clevers, H., van Oudenaarden, A., Optimality in the development of intestinal crypts. Cell 148 (2012), 608–619.
32. Jaitin, D.A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., Amit, I., Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science 343 (2014), 776–779.
33. Jaitin, D.A., Weiner, A., Yofe, I., Lara-Astiaso, D., Keren-Shaul, H., David, E., Salame, T.M., Tanay, A., van Oudenaarden, A., Amit, I., Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-seq. Cell 167 (2016), 1883–1896.
34. Jay, T.R., Miller, C.M., Cheng, P.J., Graham, L.C., Bemiller, S., Broihier, M.L., Xu, G., Margevicius, D., Karlo, J.C., Sousa, G.L., et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J. Exp. Med. 212 (2015), 287–295.
35. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P.V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A.I., Lah, J.J., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368 (2013), 107–116.
36. Junker, J.P., van Oudenaarden, A., Every cell is special: genome-wide studies add a new dimension to single-cell biology. Cell 157 (2014), 8–11.
37. Kamphuis, W., Kooijman, L., Schetters, S., Orre, M., Hol, E.M., Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease. Biochim. Biophys. Acta 1862 (2016), 1847–1860.
38. Kierdorf, K., Prinz, M., Factors regulating microglia activation. Front. Cell. Neurosci., 7, 2013, 44.
39. Kim, D., Langmead, B., Salzberg, S.L., HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12 (2015), 357–360.
40. Kimura, R., Ohno, M., Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol. Dis. 33 (2009), 229–235.
41. + monocytes in a mouse model of Alzheimer's disease. Brain 138 (2015), 2399–2422.
42. La Manno, G., Gyllborg, D., Codeluppi, S., Nishimura, K., Salto, C., Zeisel, A., Borm, L.E., Stott, S.R., Toledo, E.M., Villaescusa, J.C., et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell 167 (2016), 566–580.
43. Lai, A.Y., McLaurin, J., Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where. Future Neurol. 7 (2012), 165–176.
44. Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., Féron, F., Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol. Neurodegener., 9, 2014, 33.
45. Lara-Astiaso, D., Weiner, A., Lorenzo-Vivas, E., Zaretsky, I., Jaitin, D.A., David, E., Keren-Shaul, H., Mildner, A., Winter, D., Jung, S., et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 345 (2014), 943–949.
46. Lauro, C., Catalano, M., Trettel, F., Limatola, C., Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?. Ann. N Y Acad. Sci. 1351 (2015), 141–148.
47. Lee, S., Varvel, N.H., Konerth, M.E., Xu, G., Cardona, A.E., Ransohoff, R.M., Lamb, B.T., CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177 (2010), 2549–2562.
48. Levine, J.H., Simonds, E.F., Bendall, S.C., Davis, K.L., Amir, A.D., Tadmor, M.D., Litvin, O., Fienberg, H.G., Jager, A., Zunder, E.R., et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162 (2015), 184–197.
49. Louveau, A., Harris, T.H., Kipnis, J., Revisiting the Mechanisms of CNS Immune Privilege. Trends Immunol. 36 (2015), 569–577.
50. Ma, J., Jiang, T., Tan, L., Yu, J.T., TYROBP in Alzheimer's disease. Mol. Neurobiol. 51 (2015), 820–826.
51. Mass, E., Ballesteros, I., Farlik, M., Halbritter, F., Günther, P., Crozet, L., Jacome-Galarza, C.E., Händler, K., Klughammer, J., Kobayashi, Y., et al. Specification of tissue-resident macrophages during organogenesis. Science, 353, 2016, 10.1126/science.aaf4238.
52. Matcovitch-Natan, O., Winter, D.R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science, 353, 2016, aad8670.
53. McCombe, P.A., Henderson, R.D., The Role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med. 11 (2011), 246–254.
54. Merino, J.J., Muñetón-Gómez, V., Alvárez, M.I., Toledano-Díaz, A., Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-tau accumulation in Alzheimer's disease (AD) rodent models: is fractalkine a systemic biomarker for AD?. Curr. Alzheimer Res. 13 (2016), 403–412.
55. Mildner, A., Huang, H., Radke, J., Stenzel, W., Priller, J., P2Y12 receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases. Glia 65 (2017), 375–387.
56. Mosher, K.I., Wyss-Coray, T., Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol. 88 (2014), 594–604.
57. Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26 (2006), 10129–10140.
58. Orre, M., Kamphuis, W., Osborn, L.M., Jansen, A.H., Kooijman, L., Bossers, K., Hol, E.M., Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol. Aging 35 (2014), 2746–2760.
59. Orre, M., Kamphuis, W., Osborn, L.M., Melief, J., Kooijman, L., Huitinga, I., Klooster, J., Bossers, K., Hol, E.M., Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol. Aging 35 (2014), 1–14.
60. Ostuni, R., Piccolo, V., Barozzi, I., Polletti, S., Termanini, A., Bonifacio, S., Curina, A., Prosperini, E., Ghisletti, S., Natoli, G., Latent enhancers activated by stimulation in differentiated cells. Cell 152 (2013), 157–171.
61. Painter, M.M., Atagi, Y., Liu, C.C., Rademakers, R., Xu, H., Fryer, J.D., Bu, G., TREM2 in CNS homeostasis and neurodegenerative disease. Mol. Neurodegener., 10, 2015, 43.
62. Paul, F., Arkin, Y., Giladi, A., Jaitin, D.A., Kenigsberg, E., Keren-Shaul, H., Winter, D., Lara-Astiaso, D., Gury, M., Weiner, A., et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163 (2015), 1663–1677.
63. Paz-Y-Miño, C.A., García-Cárdenas, J.M., López-Cortés, A., Salazar, C., Serrano, M., Leone, P.E., Positive association of the Cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease. Am. J. Med. Sci. 350 (2015), 296–301.
64. Pottier, C., Ravenscroft, T.A., Brown, P.H., Finch, N.A., Baker, M., Parsons, M., Asmann, Y.W., Ren, Y., Christopher, E., Levitch, D., et al. TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol. Aging, 48, 2016 222.e9–222.e5.
65. Prinz, M., Priller, J., Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15 (2014), 300–312.
66. Quan, N., Banks, W.A., Brain-immune communication pathways. Brain Behav. Immun. 21 (2007), 727–735.
67. Rajamohamedsait, H.B., Sigurdsson, E.M., Histological staining of amyloid and pre-amyloid peptides and proteins in mouse tissue. Methods Mol. Biol. 849 (2012), 411–424.
68. Ransohoff, R.M., Cardona, A.E., The myeloid cells of the central nervous system parenchyma. Nature 468 (2010), 253–262.
69. Reitz, C., Mayeux, R., Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88 (2014), 640–651.
70. Scacchi, R., Gambina, G., Broggio, E., Moretto, G., Ruggeri, M., Corbo, R.M., The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease. Neurosci. Lett. 367 (2004), 177–180.
71. Schlegelmilch, T., Henke, K., Peri, F., Microglia in the developing brain: from immunity to behaviour. Curr. Opin. Neurobiol. 21 (2011), 5–10.
72. Schwartz, M., Shechter, R., Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol. 6 (2010), 405–410.
73. Sierra, A., Beccari, S., Diaz-Aparicio, I., Encinas, J.M., Comeau, S., Tremblay, M.E., Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis. Neural Plast., 2014, 2014, 610343.
74. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P., Rivest, S., Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006), 489–502.
75. Song, W., Hooli, B., Mullin, K., Jin, S.C., Cella, M., Ulland, T.K., Wang, Y., Tanzi, R., Colonna, M., Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. 13 (2017), 381–387.
76. Tejera, D., Heneka, M.T., Microglia in Alzheimer's disease: the good, the bad and the ugly. Curr. Alzheimer Res. 13 (2016), 370–380.
77. Thériault, P., ElAli, A., Rivest, S., The dynamics of monocytes and microglia in Alzheimer's disease. Alzheimers Res. Ther., 7, 2015, 41.
78. Tremblay, M.E., Stevens, B., Sierra, A., Wake, H., Bessis, A., Nimmerjahn, A., The role of microglia in the healthy brain. J. Neurosci. 31 (2011), 16064–16069.
79. Treutlein, B., Brownfield, D.G., Wu, A.R., Neff, N.F., Mantalas, G.L., Espinoza, F.H., Desai, T.J., Krasnow, M.A., Quake, S.R., Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 509 (2014), 371–375.
80. Turnbull, I.R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., Colonna, M., Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177 (2006), 3520–3524.
81. Wang, Y., Cella, M., Mallinson, K., Ulrich, J.D., Young, K.L., Robinette, M.L., Gilfillan, S., Krishnan, G.M., Sudhakar, S., Zinselmeyer, B.H., et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160 (2015), 1061–1071.
82. Wang, Y., Ulland, T.K., Ulrich, J.D., Song, W., Tzaferis, J.A., Hole, J.T., Yuan, P., Mahan, T.E., Shi, Y., Gilfillan, S., et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213 (2016), 667–675.
83. Winter, D.R., Jung, S., Amit, I., Making the case for chromatin profiling: a new tool to investigate the immune-regulatory landscape. Nat. Rev. Immunol. 15 (2015), 585–594.
84. Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A.M., Cialic, R., Wu, P.M., Doykan, C.E., Lin, J., Cotleur, A.C., et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211 (2014), 1533–1549.
85. Yerbury, J.J., Ooi, L., Dillin, A., Saunders, D.N., Hatters, D.M., Beart, P.M., Cashman, N.R., Wilson, M.R., Ecroyd, H., Walking the tightrope: proteostasis and neurodegenerative disease. J. Neurochem. 137 (2016), 489–505.
86. Yuan, P., Condello, C., Keene, C.D., Wang, Y., Bird, T.D., Paul, S.M., Luo, W., Colonna, M., Baddeley, D., Grutzendler, J., TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90 (2016), 724–739.
87. Zeisel, A., Muñoz-Manchado, A.B., Codeluppi, S., Lönnerberg, P., La Manno, G., Juréus, A., Marques, S., Munguba, H., He, L., Betsholtz, C., et al. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347 (2015), 1138–1142.
88. Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., Schwartz, M., Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 9 (2006), 268–275.